Changsha Morning Shine Co., Ltd. is an innovative company dedicated to promoting quality advancements in the biopharmaceutical industry through robust chemical and biological underlying technologies. Our core businesses now encompasses the development and manufacture of pharmaceutical raw materials and life science and diagnostic reagents, as well as outsourced services for pharmaceutical and biopharmaceutical research and development (R&D). Specially, our outsourced services cover contract research of chemical drug and biotechnology services, and with a leading edge in identification and preparation of challenging impurities, research on various trace impurities, and analysis of nucleic acids and proteins. In addition, our advantage products include peptide drug intermediates, nucleic acid chemical raw materials, monodisperse PEG derivatives, and dyes and labeling reagents.

With a core team comprising eminent professionals with extensive experience in pharmaceutical research and development, we have invested more than CNY100 million in state-of-the-art research instruments and equipment. Based on the comprehensive instrumentation and the cross-disciplinary team, we have established four advanced technical platforms: chemical synthesis, chemical analysis, chemical separation, and biotechnology. By fully leveraging the technical advantages of deep interdisciplinary integration of chemistry and biology, we focus on achieving breakthroughs in core technologies within the most critical areas of research and development.

Since our inception in 2019, we have garnered widespread recognition and trust from clients by consistently delivering well-grounded expertise, top-level services, and reliable products, and successfully entered into well-functioning partnerships with over 1000 global biopharmaceutical companies and research institutions. Adhering to the philosophy of "pursuing excellence in quality through technological innovation", we are dedicated to be a leading provider of superior products and services in the upstream biopharmaceutical industry.

The core team members have been engaged in new drug research and development for over a decade, with extensive experience in synthesis. We are familiar with GMP production and have a deep understanding of regulatory requirements.

We have the top-level analysis team in China to ensure that we can develop high-quality products. The head of the department has been responsible for over 100 generic drug R&D projects and has a deep understanding of product quality research.

We have developed a series of technical means such as liquid-liquid extraction, normal phase/reverse phase preparative separation, and recrystallization.

We have implemented a comprehensive and integrated Environment, Health, and Safety Management System (EHS-MS) and ISO9001 Quality Management System (QMS)

We have employed an Electronic Laboratory Notebook (ELN) integrated within the Laboratory Information Management System (LIMS), ensuring data integrity and providing clearer, more accurate, and more efficient standardized records compared to traditional paper-based documentation.

The network-based database can realize hierarchical permission management, audit tracking, real-time data backup, and ensures security and compliance.